IT201800009384A1 - Peptide for cosmetic application - Google Patents

Peptide for cosmetic application Download PDF

Info

Publication number
IT201800009384A1
IT201800009384A1 IT102018000009384A IT201800009384A IT201800009384A1 IT 201800009384 A1 IT201800009384 A1 IT 201800009384A1 IT 102018000009384 A IT102018000009384 A IT 102018000009384A IT 201800009384 A IT201800009384 A IT 201800009384A IT 201800009384 A1 IT201800009384 A1 IT 201800009384A1
Authority
IT
Italy
Prior art keywords
peptide
sequence
use according
cosmetic composition
skin
Prior art date
Application number
IT102018000009384A
Other languages
English (en)
Italian (it)
Inventor
Pablo Pellegrini
Original Assignee
Cosmo Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Srl filed Critical Cosmo Srl
Priority to IT102018000009384A priority Critical patent/IT201800009384A1/it
Priority to AU2019357261A priority patent/AU2019357261A1/en
Priority to JP2021544961A priority patent/JP2022508676A/ja
Priority to IL282064A priority patent/IL282064B/en
Priority to SG11202103026YA priority patent/SG11202103026YA/en
Priority to CN201980066612.1A priority patent/CN112823039A/zh
Priority to EP19784151.3A priority patent/EP3863728B1/en
Priority to EA202190888A priority patent/EA202190888A1/ru
Priority to BR112021006742-6A priority patent/BR112021006742A2/pt
Priority to US17/284,343 priority patent/US20210395305A1/en
Priority to KR1020217011590A priority patent/KR20210075098A/ko
Priority to CA3115025A priority patent/CA3115025A1/en
Priority to PCT/IB2019/058641 priority patent/WO2020075108A1/en
Publication of IT201800009384A1 publication Critical patent/IT201800009384A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102018000009384A 2018-10-11 2018-10-11 Peptide for cosmetic application IT201800009384A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
AU2019357261A AU2019357261A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging
JP2021544961A JP2022508676A (ja) 2018-10-11 2019-10-10 皮膚の老化および光老化の処置および予防に有効なペプチド
IL282064A IL282064B (en) 2018-10-11 2019-10-10 Peptides for use in the treatment and prevention of skin aging and photoaging
SG11202103026YA SG11202103026YA (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging
CN201980066612.1A CN112823039A (zh) 2018-10-11 2019-10-10 用于治疗和预防皮肤衰老和光老化的肽
EP19784151.3A EP3863728B1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging
EA202190888A EA202190888A1 (ru) 2018-10-11 2019-10-10 Пептид для применения в косметике
BR112021006742-6A BR112021006742A2 (pt) 2018-10-11 2019-10-10 Peptídeo, composição cosmética, e, método não terapêutico para o tratamento e prevenção do envelhecimento e fotoenvelhecimento da pele
US17/284,343 US20210395305A1 (en) 2018-10-11 2019-10-10 Peptide for cosmetic application
KR1020217011590A KR20210075098A (ko) 2018-10-11 2019-10-10 피부 노화 및 광 노화 치료 및 예방에 사용하기 위한 펩타이드
CA3115025A CA3115025A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application

Publications (1)

Publication Number Publication Date
IT201800009384A1 true IT201800009384A1 (it) 2020-04-11

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application

Country Status (13)

Country Link
US (1) US20210395305A1 (cg-RX-API-DMAC7.html)
EP (1) EP3863728B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022508676A (cg-RX-API-DMAC7.html)
KR (1) KR20210075098A (cg-RX-API-DMAC7.html)
CN (1) CN112823039A (cg-RX-API-DMAC7.html)
AU (1) AU2019357261A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021006742A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115025A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190888A1 (cg-RX-API-DMAC7.html)
IL (1) IL282064B (cg-RX-API-DMAC7.html)
IT (1) IT201800009384A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202103026YA (cg-RX-API-DMAC7.html)
WO (1) WO2020075108A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR102773595B1 (ko) * 2021-05-28 2025-02-27 주식회사 엘지생활건강 세노모르픽스용 또는 피부 노화 방지용 조성물
KR102726837B1 (ko) * 2021-09-29 2024-11-07 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102774179B1 (ko) * 2021-09-29 2025-03-04 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102877905B1 (ko) * 2021-09-30 2025-10-30 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102736940B1 (ko) * 2021-09-30 2024-12-03 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
WO1999039728A2 (en) 1998-02-04 1999-08-12 Trustees Of Boston University Methods of inducing hair growth and coloration
WO2004026329A1 (en) 2002-09-19 2004-04-01 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
WO2005019266A2 (en) 2003-07-15 2005-03-03 Amgen Inc. Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
KR20100058858A (ko) * 2008-11-25 2010-06-04 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
WO2011049758A1 (en) 2009-10-09 2011-04-28 Amgen Inc. Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
WO2011116090A1 (en) 2010-03-17 2011-09-22 Abbott Research B.V. Anti-nerve growth factor (ngf) antibody compositions
WO2013065078A2 (en) 2011-11-02 2013-05-10 Sampo S.R.L. Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN107286233A (zh) * 2016-04-13 2017-10-24 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848A (zh) * 2017-12-28 2018-05-01 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
MX2009010757A (es) * 2007-04-06 2010-02-24 Kai Pharmaceuticals Inc Metodos de uso de compuestos de inhibidor gamma para atenuacion del dolor.
IT1394690B1 (it) * 2008-10-23 2012-07-13 Carli De Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf.
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
FR2961814B1 (fr) * 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
CA2818610C (en) * 2010-11-18 2020-02-18 Steven Yoelin Compositions and methods for hair growth
BR112018005587A8 (pt) * 2015-09-22 2022-08-09 Currahee Holding Company Inc Métodos para aprimorar a aplicação tópica de um agente de benefício básico

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
WO1999039728A2 (en) 1998-02-04 1999-08-12 Trustees Of Boston University Methods of inducing hair growth and coloration
WO2004026329A1 (en) 2002-09-19 2004-04-01 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
WO2005019266A2 (en) 2003-07-15 2005-03-03 Amgen Inc. Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
KR20100058858A (ko) * 2008-11-25 2010-06-04 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
WO2011049758A1 (en) 2009-10-09 2011-04-28 Amgen Inc. Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
WO2011116090A1 (en) 2010-03-17 2011-09-22 Abbott Research B.V. Anti-nerve growth factor (ngf) antibody compositions
WO2013065078A2 (en) 2011-11-02 2013-05-10 Sampo S.R.L. Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN107286233A (zh) * 2016-04-13 2017-10-24 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848A (zh) * 2017-12-28 2018-05-01 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"A Review on Ultrasound Parameters and Methods of Application in Transdermal Drug Delivery", INTERNATIONAL JOURNAL OF HEALTH SCIENCES & RESEARCH, vol. 5, no. 5, May 2015 (2015-05-01), pages 477
"CTFA International Cosmetic Ingredient Dictionary and Handbook", 1997, THE COSMETIC, TOILETRY, AND FRAGRANCE ASSOCIATION, INC.
A. TRAVAGLIA ET AL.: "A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells", ACS CHEM NEUROSCI, vol. 6, no. 8, 19 August 2015 (2015-08-19), pages 1379 - 92
ALTSCHUL ET AL., MOL. BIOL., vol. 215, 1990, pages 403 - 410
C. FOX, COSMETICS AND TOILETRIES, vol. 101, November 1986 (1986-11-01), pages 101 - 112
CHAO MV; HEMPSTEAD BL.: "p75 and Trk: a two-receptor system", TRENDS NEUROSCI, vol. 18, 1995, pages 321 - 6, XP000907021, DOI: doi:10.1016/0166-2236(95)93922-K
FRICKER J., LANCET, vol. 349, 1997, pages 480
HEFTI F., J. NEUROBIOL., vol. 25, 1994, pages 1418
J. MILBRANDT: "Nerve growth factor rapidly induces c-fos mRNA in PC12 rat pheochromocytoma cells", PROC NATL ACAD SCI USA, vol. 83, no. 13, July 1986 (1986-07-01), pages 4789 - 93
MEAKIN SO; SHOOTER EM: "The nerve growth factor family of receptors", TRENDS NEUROSCI., vol. 15, 1992, pages 323 - 31, XP024346880, DOI: doi:10.1016/0166-2236(92)90047-C
OLSON L. ET AL., J. NEURAL TRANS.: PARKINSON'S DISEASE AND DEMENTIA SECTION, vol. 4, 1992, pages 79
P. DI PIETRO ET AL.: "Immobilization of Neurotrophin Peptides on Gold Nanoparticles by Direct and Lipid-Mediated Interaction: A New Multipotential Therapeutic Nanoplatform for CNS Disorders", ACS OMEGA, vol. 2, no. 8, 2017, pages 4071 - 4079
PETTY B.G. ET AL., ANNALS OF NEUROLOGY, vol. 36, 1994, pages 244 - 246
SATRIANO ET AL.: "Neurotrophin-mimicking peptides at the biointerface with gold respond to copper ion stimuli", PHYSICAL CHEMISTRY CHEMICAL PHYSICS, vol. 18, no. 44, 2016, pages 30595 - 30604

Also Published As

Publication number Publication date
US20210395305A1 (en) 2021-12-23
JP2022508676A (ja) 2022-01-19
WO2020075108A1 (en) 2020-04-16
CN112823039A (zh) 2021-05-18
KR20210075098A (ko) 2021-06-22
BR112021006742A2 (pt) 2021-09-21
AU2019357261A1 (en) 2021-05-13
EP3863728B1 (en) 2026-07-15
EP3863728A1 (en) 2021-08-18
SG11202103026YA (en) 2021-04-29
EA202190888A1 (ru) 2021-07-07
IL282064B (en) 2022-09-01
IL282064A (en) 2021-05-31
CA3115025A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
US20210395305A1 (en) Peptide for cosmetic application
KR101393397B1 (ko) 세포내 분자 전송 펩티드를 이용한 피부 생리 활성 분자의 경피 전달시스템
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
CN107080831A (zh) 短抗微生物脂肽
ES2653388T3 (es) Composición dermofarmacéutica o cosmética que comprende péptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales
CN113549139A (zh) 一种芋螺多肽、多肽组合物及其制备方法和应用
CA3213099A1 (en) Peptides and methods for reducing skin pigmentation
JP2026004423A (ja) 皮膚及びその付属器の、ペプチドに基づいた化粧品又は皮膚科学的な処置
KR101814049B1 (ko) 펩타이드를 유효성분으로 함유하는 피부 미백용 화장료 조성물
ITRM20130199A1 (it) Peptidi per uso dermatologico e/o cosmetico
US8450456B2 (en) Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
JP7854982B2 (ja) 皮膚科領域における治療用途のためのペプチド
TWI634123B (zh) 刺激黑色素生成的胜肽、方法及組合物
US8304392B2 (en) Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
CN110023325B (zh) 具有提高的生物活性和降低的对嗜中性粒细胞弹性蛋白酶降解易感性的来源于纤连蛋白的肽
JP2016196464A (ja) 角質層内で発現されるポリペプチドおよびその使用
TWI614022B (zh) 降低黑色素含量的胜肽、方法及組合物
JP7695716B2 (ja) 化粧品および医薬品に使用するためのペプチドおよび組成物
CN114929192B (zh) 包含改善皮肤外观和再生的新型肽的用于局部施用的美容制剂
JP2022510972A (ja) エンドセリン－１の分泌、幹細胞因子の合成、及びタンパク質のカルボニル化を減少させるための白マツの樹皮抽出物
CN113015538B (zh) 用于皮肤病学和美容应用的包含酰化四肽的组合物
KR102089754B1 (ko) 피부투과성이 개선된 탈모 억제 또는 발모 촉진용 조성물